Vasculitis & polymyalgia rheumatica

Cardiovascular diseases and their associations with lipid parameters and endothelial dysfunction in giant cell arteritis

RMD OpenPublished Prospective cohort study

Authors' conclusion

GCA patients are at a high risk of developing cardiovascular diseases. Of relevance, there was underuse of statins and a large proportion of these patients showed LDL cholesterol concentrations above the treatment targets for high-risk patients.

Study context

Population
Patients with giant cell arteritis (GCA) and controls evaluated in 2012, follow-up by chart review in 2020
Participants
138 vs 100
Exposure
GCA patients vs controls
  • GCAn = 138
  • Controlsn = 100reference
Outcome
Prevalence and development of CVD; endothelial dysfunction and lipid metabolism
Methodological detailscontrolled, chart review follow-up to 2020
  • Controlled
  • Chart review follow-up to 2020

Main finding

As reported in the abstract

Prevalent carotid and vertebral artery disease higher in GCA than controls
p<0.001
GCA had higher total cholesterol, low-density lipoprotein (LDL), intermediate-density lipoprotein, HDL, apolipoprotein A1 and B, and augmentation index
all with p<0.05
Target LDL levels less frequently achieved at inclusion by GCA
p=0.001
GCA developed new CV events more frequently, also with a higher amount, during follow-up
all with p<0.001

Observational data: associations, not effects.

Further findings

Relapse and future CV events (GCA)

OR (95% CI)P value
RelapseIndependently associated5.01 (1.55–16.22)P = 0.007

Statin treatment in GCA and asymmetric dimethylarginine, monocytes and CRP

Statin treatment associated with lower asymmetric dimethylarginine, monocytes and CRP
all with p<0.05

Original publication

Cardiovascular diseases and their associations with lipid parameters and endothelial dysfunction in giant cell arteritis. RMD Open. Published 1 September 2023. doi:10.1136/rmdopen-2023-003481

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.